loading

Clinical Testing Solutions for Child-Safe Cosmetics Issued by SGS

Safety is the highest priority when testing cosmetic products for children, and adherence to strict regulations and guidelines is essential. A widely recommended approach is to initially test products on adult volunteers to establish a baseline for safety before considering any tests involving children. This ensures that potential risks are thoroughly minimized, and any harmful effects are promptly identified.

For products specifically designed for children, such as diapers or baby wipes, safety evaluations can be performed using adult volunteers under highly controlled and exaggerated conditions, such as patch testing. To better mimic the characteristics of children's skin, it is strongly advised that a substantial portion of adult volunteers have sensitive skin.

Testing cosmetic products on children should strictly exclude high-risk ingredients due to their skin being far more delicate and sensitive than that of adults. This strategy allows manufacturers to preemptively identify and address potential risks, ensuring the product's safety for these most vulnerable users.

There are several clinical safety testing solutions below to verify product safety and substantiate related claims:

1. Primary dermal irritation test: Determines if the product will cause immediate irritation when applied to the skin. A small amount of the product is applied to a specific area of the skin, usually under a patch. The application site is then monitored for a short period for signs of redness, swelling or irritation.

Claims substantiated:

Gentle on skin

Non-irritating

Non-irritating to sensitive skin

2. Cumulative irritation test: Evaluates whether repeated use of the product over time causes skin irritation. The product is applied repeatedly to the same skin area over several days to simulate regular use. The skin is then observed for signs of irritation, redness or damage.

Claims substantiated:

Gentle on skin for repeated use

Mild for long-term use

Clinical Testing Solutions for Child-Safe Cosmetics Issued by SGS 1

3. Human repeated induction patch test (HRIPT): Assesses whether a product may cause allergic reactions after repeated exposure. The product is applied to the skin multiple times over three weeks, followed by a rest period and a final challenge application. The skin is closely monitored for allergic responses like redness, swelling or rashes.

Claims substantiated:

Non-inducer of allergic response

Pediatrician reviewed

Dermatologically tested for sensitive skin

4. Phototoxicity and photoallergy tests: Evaluate whether a product triggers adverse skin reactions when exposed to sunlight or UV radiation. The product is applied to the skin and exposed to UV light. The site is then observed for redness, rashes or swelling.

Claims substantiated:

Non-photosensitizing

Gentle on skin under sunlight

5. Ocular tear-free test: Determines if a product is gentle on the eyes and does not cause irritation or tears. The product is tested in vitro, using models that replicate eye tissue, and subsequently in vivo on human volunteers under controlled conditions. The eyes are monitored for irritation, redness or discomfort.

Claims substantiated:

Tear-free

Ophthalmologist tested

Gentle for sensitive eyes

By conducting these rigorous safety evaluations, manufacturers and brands can ensure that their products meet the highest safety standards for adults and are well-prepared to undertake safety testing on children when necessary and appropriate.

(Written by Saeid Amini Nik, Issued by SGS-CSTC Standards Technical Services Co., Ltd., April 8, 2025)

prev
MoCRA and the Safety Review Process for Children's Cosmetics Issued by SGS
Lily Achieves Historic Breakthroughs at Hong Kong Gifts & Premium Fair and Canton Fair
next
recommended for you
no data
Get in touch with us
With deep culture, keep facing future in Beauty & Personal Care field.
Customer service
detect